See Important Safety Information, including Boxed Warning. How AUSTEDO XR® (deutetrabenazine) extended-release tablets may help.

Aug 20, 2025 · Austedo is used to treat the involuntary movements of Huntington's disease and tardive dyskinesia (TD). Includes Austedo side effects, dosage, uses, interactions, and more

Find downloadable resources to help you support patients with TD throughout treatment. View helpful videos about TD and AUSTEDO XR. See Prescribing Information, including Boxed Warning.

Jun 26, 2024 · Find patient medical information for Austedo (deutetrabenazine) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings

Mar 18, 2026 · Review Austedo (Deutetrabenazine) for managing Huntington's chorea and tardive dyskinesia. Explore our comprehensive medical safety and dosage protocols.

U.S. FDA approves new one pill, once-daily AUSTEDO XR tablets (30, 36, 42, 48 mg/day) AUSTEDO XR offers more flexibility with the most once-daily doses of any vesicular monoamine transporter 2 …

The FDA has approved a new one-pill, once-daily tablet administration option for deutetrabenazine (Austedo XR; Teva Pharmaceuticals), a medication for tardive dyskinesia and chorea associated …

Nov 12, 2025 · New phase 4 data reveals Austedo significantly reduces involuntary movements and enhances quality of life for adults with tardive dyskinesia.

Mar 21, 2024 · Learn about tardive dyskinesia, a side effect of antipsychotic medications that causes involuntary movements. Discover the causes, symptoms, diagnosis, and treatment options for this …

Lactation Risk Summary: There are no data on the presence of deutetrabenazine or its metabolites in human milk, the effects on the breastfed infant, or the effects of the drug on milk production. The …